What the supplied label says
100 mg extract, standardized to 65% boswellic acid per capsule. This comes from the supplied Supplement Facts label; check the actual bottle for updates.
Explore this review
What the supplied label saysHow to interpret this ingredientRead it in the full formulaWhy 65% is not a complete trial matchSources used on this pageHow to interpret this ingredient
The supplied label names Boswellia serrata gum-resin extract. The standardization adds useful detail beyond a generic botanical name. At the listed percentage, 100 mg corresponds to 65 mg of the specified boswellic-acid component; it does not reveal the amount of each individual acid.
NCCIH’s boswellia overview describes small studies and limited high-quality evidence. A named extract in a trial can have a different profile from this label entry. Compare the actual formulation rather than assuming every boswellia preparation has identical results.
A larger milligram figure on another bottle is not a complete quality comparison either. Preparation, standardization, clinical evidence and the total serving all belong in the same assessment.
Read it in the full formula
One ingredient cannot settle the assessment of a multi-ingredient product. Review all five label entries, the evidence standard and safety questions together. Ingredient identity, preparation, dose and the person taking it all matter.
Why 65% is not a complete trial match
The label gives a percentage of boswellic acid but does not individually quantify every constituent. A study of a specially enriched extract might rely on a different profile, delivery system or comparison. Equal total extract weight cannot resolve those differences.
A useful comparison sheet has four fields: extract weight, the exact standardization, daily servings and the preparation tested in the reference. If the paper reports a specific constituent that the supplied panel does not quantify, write “not disclosed” rather than treating 65% as the same measurement.
The goal is not to label every difference good or bad. It is to avoid presenting an uncertain match as a proven clinical dose. Read the independent overview and the full formula together before drawing a conclusion about the combined product.